Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 577.31 million compared to CNY 548.43 million a year ago. Revenue was CNY 583.51 million compared to CNY 554.22 million a year ago.

Net income was CNY 317.16 million compared to CNY 165.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.31 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.31 compared to CNY 0.16 a year ago.